Levothyroxine sodium
- Product NDC
- 0480-8704
- Requested package NDC
- 0480-8704-01
- 11-digit product format
- 004808704
- Labeler code
- 0480
- Product ID
- 0480-8704_8f65417f-488f-4e4a-894c-56f99ed57d25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA207588
- Marketing category
- ANDA
- Marketing start
- 2022-09-21
- Marketing end
- 2026-10-31
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 112 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0480-8704 | 0480-8704-01 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0480-8704 | 0480-8704-01 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207588-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207588-001 | AB1 |
| A207588-001 | AB2 |
| A207588-001 | AB3 |
| A207588-001 | AB4 |
| A207588-002 | AB1 |
| A207588-002 | AB2 |
| A207588-002 | AB3 |
| A207588-002 | AB4 |
| A207588-003 | AB1 |
| A207588-003 | AB2 |
| A207588-003 | AB3 |
| A207588-003 | AB4 |
| A207588-004 | AB1 |
| A207588-004 | AB2 |
| A207588-004 | AB3 |
| A207588-004 | AB4 |
| A207588-005 | AB1 |
| A207588-005 | AB2 |
| A207588-005 | AB3 |
| A207588-005 | AB4 |
| A207588-006 | AB1 |
| A207588-006 | AB2 |
| A207588-006 | AB3 |
| A207588-006 | AB4 |
| A207588-007 | AB1 |
| A207588-007 | AB2 |
| A207588-007 | AB3 |
| A207588-007 | AB4 |
| A207588-008 | AB1 |
| A207588-008 | AB2 |
| A207588-008 | AB3 |
| A207588-008 | AB4 |
| A207588-009 | AB1 |
| A207588-009 | AB2 |
| A207588-009 | AB3 |
| A207588-009 | AB4 |
| A207588-010 | AB1 |
| A207588-010 | AB2 |
| A207588-010 | AB3 |
| A207588-010 | AB4 |
| A207588-011 | AB1 |
| A207588-011 | AB2 |
| A207588-011 | AB3 |
| A207588-011 | AB4 |
| A207588-012 | AB1 |
| A207588-012 | AB2 |
| A207588-012 | AB3 |
| A207588-012 | AB4 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB4 | 4 | 011fe1cb6892… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine sodium
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVOTHYROXINE SODIUM | 112 ug/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9J765S329G | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 892246 | Internal RxNorm lookup |
| 892251 | Internal RxNorm lookup |
| 892255 | Internal RxNorm lookup |
| 966220 | Internal RxNorm lookup |
| 966221 | Internal RxNorm lookup |
| 966222 | Internal RxNorm lookup |
| 966224 | Internal RxNorm lookup |
| 966225 | Internal RxNorm lookup |
| 966248 | Internal RxNorm lookup |
| 966249 | Internal RxNorm lookup |
| 966253 | Internal RxNorm lookup |
| 966270 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 60cadfd7-82b5-4207-97e1-1dd0655efb27 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 97c252d3-9bb8-4530-bb44-9824dc7cf556 | Product name | 6 | 20250729 |
| 6c43b71c-35e6-4db3-ba24-c6ef42ff7003 | Product name | 3 | 20240207 |
| 890fd4bf-1a80-42b7-be1b-2d0259d5f0c8 | Product name | 5 | 20240207 |
| c8ad26bf-af73-460b-b74e-1eff16cc4f9f | Product name | 5 | 20240207 |
| 01383843-4069-43cf-aa76-dc17a6f9f8c4 | Product name | 2 | 20230123 |
| 978cca7d-a938-4791-8322-da48d90a63ef | Product name | 1 | 20230113 |
| 65f86ba3-8816-4e12-899b-18290c8de551 | Product name | 2 | 20210614 |
| f16ab90f-08c2-40be-a543-66d9827cd1f3 | Product name | 1 | 20210601 |
| 6a33ec05-2ae2-45e5-ab82-2d94b3303923 | Product name | 1 | 20190709 |
| 93355a10-1c44-4c92-a11d-7d995e0200d9 | Product name | 1 | 20190219 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0480-8704-01 | Levothyroxine sodium | 100 in 1 BOTTLE | TABLET | 100 | 8 | |
| 0480-8704-10 | Levothyroxine sodium | 1000 in 1 BOTTLE | TABLET | 1000 | 8 | |
| 0480-8704-98 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0480-8704-01 | EA - Each | 0480-8704 | aa00e410-254b-4436-bbb2-3893a27cd7af | 1 | 2022-10-06 |
| 0480-8704-10 | EA - Each | 0480-8704 | d6f07c46-9c06-43a0-91f6-3ab47744bca3 | 1 | 2022-10-06 |
| 0480-8704-98 | EA - Each | 0480-8704 | 3c6f2e70-bae9-4578-ab42-311b0601eed0 | 1 | 2022-10-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 64aaeba7-1013-44a4-96fc-b876016897b3 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 65b266af-72a5-4409-ab55-bd14341135aa | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 702016f6-8507-471f-b833-3a582aef5d2e | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a55e735f-a5b0-4b85-9fd7-3a4b6723a81b | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e1f77539-2156-4890-baca-8b13779c745c | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b4f8dfd0-b15a-4da5-a0d0-ad768e0b7ff8 | 2024-09-01 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Teva Pharmaceuticals, Inc. | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 0480-8704-01 0480-8704 00480870401 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966270 | levothyroxine sodium 137 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966249 | levothyroxine sodium 175 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892251 | levothyroxine sodium 200 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892255 | levothyroxine sodium 300 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | PSN | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966220 | levothyroxine sodium 0.025 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966221 | levothyroxine sodium 0.05 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966222 | levothyroxine sodium 0.075 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966253 | levothyroxine sodium 0.088 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892246 | levothyroxine sodium 0.1 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966248 | levothyroxine sodium 0.112 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966224 | levothyroxine sodium 0.125 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966270 | levothyroxine sodium 0.137 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966225 | levothyroxine sodium 0.15 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966249 | levothyroxine sodium 0.175 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892251 | levothyroxine sodium 0.2 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892255 | levothyroxine sodium 0.3 MG Oral Tablet | SCD | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966270 | levothyroxine sodium 137 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966249 | levothyroxine sodium 175 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892251 | levothyroxine sodium 200 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 892255 | levothyroxine sodium 300 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | SY | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 8 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | PSN | 65b266af-72a5-4409-ab55-bd14341135aa | 2 |
| 966248 | levothyroxine sodium 0.112 MG Oral Tablet | SCD | 65b266af-72a5-4409-ab55-bd14341135aa | 2 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | SY | 65b266af-72a5-4409-ab55-bd14341135aa | 2 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | PSN | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 1 |
| 966248 | levothyroxine sodium 0.112 MG Oral Tablet | SCD | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 1 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | SY | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0480-8704-01 | 00480870401 | 100 TABLET in 1 BOTTLE (0480-8704-01) | 100 tablet | 2022-09-21 | 0000-00-00 | No | No | Current |